Secondly, KRN7000, a synthetic alpha-galactosylceramide [167], showed promising results in enhancing NK, NKT, CD8+ T cells and M1 infiltration in the syngeneic murine B16 metastatic melanoma model [168] but further investigation needs to be conducted. The gene discussed is CD8A; the disease is metastatic melanoma.